Fatty acid-mediated signaling as a target for developing type 1 diabetes therapies.
Díaz Ludovico I, Sarkar S, Elliott E, Virtanen SM, Erlund I, Ramanadham S, Mirmira RG, Metz TO, Nakayasu ES.
Díaz Ludovico I, et al. Among authors: nakayasu es.
Expert Opin Ther Targets. 2023 Jul-Dec;27(9):793-806. doi: 10.1080/14728222.2023.2259099. Epub 2023 Sep 14.
Expert Opin Ther Targets. 2023.
PMID: 37706269
Free PMC article.
Review.